Precision Bio LogoHelix Header Image

DNE’s potential to target and inactivate viral or bacterial genes represents a novel, broadly-applicable, and greatly needed means of treating infectious diseases.

The technology also has the potential to meet the critical safety requirements for human gene therapy use.  No other technology has the necessary level of specificity to precisely target gene correction within the human genome or is versatile enough to treat a wide range of genetic disorders.

 

 

BioTherapeutics  

Anti-infective Therapeutics – Target and disrupt specific pathogen genes

Antibiotic Additives – Create an antibiotic additive that prevents antibiotic resistance in bacteria

Cancer Therapy – Prevent or halt disease through the manipulation of oncogenes

Gene Repair – Correct disease-causing gene mutations such as those that cause cystic fibrosis and sickle cell anemia

Stem Cell Therapeutics – Manipulate stem cell genomes to produce therapeutic cell populations

 

 

 

© 2006 Precisions BioSciences, Inc